About
About The Event
FAQ
Agenda
Get Involved
Programs
Search Agenda
In-Person Breakouts
Short Courses
Plenary Sessions
Speaker Biographies
Training Seminar
Attendees
Networking
Archives
Sponsor/Exhibitor
Attendee Demographics + Event Features
Sponsorship Opportunities
Current Sponsors
Current Exhibitors
Exhibit Services Schedule
Exhibitor Prospectus
Lead Generation Opportunities
FAQs
Sponsor & Exhibitor Portal
Best of Show Awards
Media
Media Partners
Downloads
Media Gallery
Travel
Posters
Poster Information
Poster Titles
Register
Individual Pricing
Group Pricing
On Demand Pricing
Press
Archives
Discovery on Target - September 30-October 3, 2024
Discovery on Target - September 25-28, 2023
Discovery on Target - October 17-20, 2022
Discovery on Target - September 27-30, 2021
Discovery on Target - September 15-18, 2020
Discovery on Target - September 16-19, 2019
Discovery on Target - September 25-28, 2018
Discovery on Target - September 25-29, 2017
Discovery on Target - September 19-22, 2016
Discovery on Target - September 21-24, 2015
Discovery on Target - October 8-10, 2014
Discovery on Target - September 24-26, 2013
Discovery on Target - October 1-3, 2012
Discovery on Target - November 2-4, 2011
Discovery on Target - November 2-4, 2010
Discovery on Target - November 2-4, 2009
#BostonDOT
Conference Programs
September 22
Covalent Chemistries & Induced Proximity
Strategies for Targeting Kinases
Emerging Immune Modulation Strategies
3D Models & NAMs in Drug Development
Synthetic Biology for Drug Discovery & Development
September 23-24
Degraders & Molecular Glues – Part 1
Emerging Drug Targets: Identification & Validation
Small Molecules for Cancer Targets
Antibodies Against Membrane Protein Targets
RNA & DNA Targeting Small Molecule Drugs
AI/ML-Enabled Drug Discovery - Part 1
Targeting MASH & Obesity
NEW
TS8: Know Your GPCR Molecule: Four Most Common Causes of Drug Candidate Failure
September 24-25
Degraders & Molecular Glues – Part 2
Lead Generation Strategies
Emerging Cancer Targets for Multispecifics, ADCs, and Biologics
GPCR-Based Drug Discovery
Targeting Transcription Factors & Regulators
AI/ML-Enabled Drug Discovery - Part 2
TS7: Drug Exposure at the Target: The Role of ADME and Pharmacokinetics